|[January 10, 2013]
Pathway Genomics Names Todd G. Johnson as Vice President of Sales and Marketing
SAN DIEGO --(Business Wire)--
Genomics Corporation, a San Diego-based clinical laboratory that
offers genetic testing services internationally, today announced it has
appointed Todd G. Johnson, MBA, as vice president of sales and
marketing. Based at Pathway Genomics' San Diego headquarters, in this
executive management position, Johnson will assume responsibility for
leading the company's domestic sales division, as well as its marketing
and client services teams.
"Todd has a wealth of experience in diagnostics and CLIA laboratories,
and has managed sales teams of more than 100 individuals at world-class
companies," said Jim Plante, Pathway Genomics' founder and CEO.
Johnson brings over two decades of sales and marketing experience to
Pathway Genomics. Prior to joining the company, he served in various
sales and marketing leadership roles for medical device and service
companies, including Abbott Laboratories (Diagnostic Division), Ventana
Medical Systems, Biocept Laboratories, Insight Health and LabCorp. He
has functioned as an executive with small biotech to multibillion-dollar
firms with reveues exceeding $500 million annually and has supervised
more than 135 sales and marketing personnel.
"Pathway Genomics possesses a truly client-focused culture that is
committed to accuracy and medical responsibility," said Johnson. "My
goal is to strengthen its evolution into a leader in genetic testing."
Johnson has a Bachelor of Science degree from the United States Military
Academy at West Point, an MBA from Webster University, and he served
globally in the United States Army as a helicopter pilot.
About Pathway Genomics
Pathway Genomics owns and operates an on-site genetic
testing laboratory that is accredited by the College
of American Pathologists (CAP), accredited in accordance with the U.S.
Health and Human Services' Clinical Laboratory Improvement Amendments
(CLIA) of 1988, and licensed by the state of California. Using only
a saliva sample, the company incorporates customized and scientifically
validated technologies to generate personalized reports, which address a variety
of medical issues, including an individual's carrier status for
recessive genetic conditions, food metabolism and exercise response,
prescription drug response, and propensity to develop certain diseases
such as heart disease, type 2 diabetes and cancer. For more information
about Pathway Genomics, visit www.pathway.com.
[ Back To Technology News's Homepage ]